无直肠患者中应用影像融合技术的新型前列腺穿刺活检技术
一例70岁因溃疡性结肠炎行全结肠切除术后无直肠的男性,因PSA升高(8.01)及MRI发现PIRADS 4病灶转诊。采用术前多参数前列腺MRI与术中超低剂量锥形束CT行3D/3D融合,经会阴三角定位法完成27针前列腺穿刺,检出Grade group 5(Gleason 4+5=9)前列腺癌。
要点
- 无直肠患者可采用术前MRI与术中超低剂量CT 3D/3D融合引导经会阴前列腺穿刺。
- 本例共获取27针组织,其中靶病灶2针及前列腺基底部1针检出Grade group 5前列腺癌。
- 该技术较典型CT引导穿刺针数超过三倍且辐射剂量更低。
核心结论
- 这是首例报告在无直肠患者中使用影像融合技术行透视引导前列腺穿刺活检,该技术能精准识别局限性极高危前列腺癌,针数超过典型CT引导穿刺的三倍且辐射剂量更低,作者认为该技术可能为靶向前列腺穿刺提供新范式。
研究设计与样本
- 技术报告:一例70岁男性,因溃疡性结肠炎行全结肠切除术后无直肠,因PSA升高(8.01)及MRI发现PIRADS 4病灶转诊,接受术前多参数前列腺MRI与术中CT 3D/3D融合引导的经会阴前列腺穿刺。
主要发现
- 全身麻醉下仰卧位使用机器人臂透视系统(Artis Zeego Care+Clear,Siemens)行超低剂量锥形束CT,将MRI与超低剂量CT的股骨头及前列腺进行3D/3D自动配准,标记前列腺边缘及两个关注区域后,以三角定位技术行减低剂量透视引导经会阴前列腺穿刺,共获取27针组织。
- 靶病灶2针及前列腺基底部1针检出Grade group 5(Gleason 4+5=9)前列腺癌,其余24针未见恶性肿瘤。
- 手术时间81分钟,PSMA扫描未见转移或淋巴结肿大,行机器人辅助腹腔镜根治性前列腺切除术无并发症,最终病理为T3a、Grade group 5前列腺腺癌,累及前列腺体积10%,手术切缘阴性。
临床怎么用
- 作者认为该技术可能为靶向前列腺穿刺提供新范式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A 70-year-old male with prior total colectomy for ulcerative colitis was referred for elevated prostate specific antigen (PSA) (8.01) with PIRADS 4 lesion on magnetic resonance imaging (MRI). Described is a novel technique using pre-operative multi-parametric prostate MRI and intraoperative computed tomography (CT) 3D/3D fusion for systematic and targeted prostate biopsy in a patient lacking a rectum. TECHNICAL CONSIDERATIONS: Under general anesthesia, an ultra-low-dose (ULD) cone beam CT was performed in supine position using a robotic-armed fluoroscopy system (Artis Zeego Care+Clear, Siemens). 3D/3D auto-registration of the femoral heads and prostate from the MRI and ULD CT was performed. The prostate edges and two areas of concern were marked. Then, reduced-dose fluoroscopy-guided prostate biopsy was performed transperineally using triangulation technique. 27 prostate biopsy cores were obtained. Grade group 5 (Gleason 4+5=9) prostate cancer was identified in two cores from the targeted lesion and one core from the prostate base. The remaining twenty-four biopsies were negative for malignancy. Surgical time was 81 minutes. PSMA scan demonstrated no metastasis or lymphadenopathy. Robotic-assisted laparoscopic radical prostatectomy was performed without complications. Final pathology demonstrated T3a, grade group 5 prostate adenocarcinoma involving 10% of the prostate volume with negative surgical margins. CONCLUSION: This is the initial report of fluoroscopy-guided prostate biopsy using imaging fusion techniques in a patient without a rectum. This technique allowed precise identification of localized, very high-risk prostate cancer with over three times the number of cores, and much lower radiation dose, than typical CT-guided biopsies. Our technique could provide a new paradigm in targeted prostate biopsy.
引用
- Sawyer MD, Kim FJ, Wiesen B, et al. Novel Prostate Biopsy Technique Using Imaging Fusion in a Patient With Absent Rectum. Urology. 2024. PMID: 38309595. doi:10.1016/j.urology.2023.12.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。